dalteparin has been researched along with Bronchitis in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salameh, A | 1 |
| Klein, M | 1 |
| Klein, N | 1 |
| Pfeiffer, D | 1 |
| Dähnert, I | 1 |
| Dhein, S | 1 |
| Krasnowska, M | 1 |
| Kwaśniewski, A | 1 |
| Rabczyński, J | 1 |
| Kuryszko, JJ | 1 |
2 other studies available for dalteparin and Bronchitis
| Article | Year |
|---|---|
Coughing into the darkness.
Topics: Adult; Anticoagulants; Bronchitis; Carotid Artery, Internal; Constriction, Pathologic; Cough; Drug A | 2011 |
[The influence of heparin on the course of bronchitis experimentally provoked by sulfur dioxide in rats in evaluation of lung histology and cytology of bronchial alveolar lavage fluid].
Topics: Administration, Inhalation; Animals; Bronchitis; Bronchoalveolar Lavage Fluid; Fibrinolytic Agents; | 1997 |